Quest 2022

Inviting Innovations in Infectious Diseases

About Quest

Purpose

Innovations in the infectious diseases segment have historically suffered from de-prioritization in terms of investments. The Quest has been an attempt of IHF to scout and support innovations for infectious diseases since 2017. This year IHF, BCKICF and KIIT-TBI are jointly launching QUEST 2022 with the intent of finding novel solutions to some of the most pressing problems affecting the control, care, and cure of infectious diseases. Read more

A Joint Initiative By:
Supported By:

Focus Areas

Screening and Diagnosis

Solutions that are point of care, portable, rapid, accurate, and easily interfaced with health systems


Care Pathways

Proven technologies that can improve the care continuum and ensure availability and accessibility of healthcare at primary levels

Disease Surveillance

Innovations to support disease surveillance to effectively strengthen the health systems for responsive, timely and appropriate actions for control of disease outbreaks

Quest 2022
Program Document

Please refer to the program document to get a holistic understanding of Quest 2022.

Program Offerings

Funding Support

Milestone-based funding support

Product Validation

Support with building linkages for evidence generation with relevant public, private, academic and research institutions

Mentoring

Need-based mentoring by a panel of experts

Market Access

Access to resources for adoption in the health system and acceleration

Evaluation Criteria

Novelty

Uniqueness of the idea/technology/solution

Impact

Demonstrated/potential ability of the innovations to impact health outcomes upto primary care level

Multi-disease Potential

Ability of the innovation to be adapted to multiple disease areas

Scalability

Competitiveness on quality, cost, timeliness, and service levels to ensure adoption

Sustainability

An underlying business model/value proposition for sustainable impact

Eligibility

  • Promising proposals at TRL 5, 6 & 7 will be supported for product development, clinical validation, regulatory approvals, and multicentric trials
  • Promising innovations at TRL 8 & 9 will be supported for evidence demonstration, community validation and acceleration. 

Timelines

23rd May 2022, 17:00 hrs
14th June 2022
10th July 2022
15th July 2022
20th July 2022
1st - 4th August 2022*
16th August - 30th September 2022

Contact Us

For any queries, applicants can write to [email protected] / [email protected]

FAQs

No, you cannot edit your application after you have submitted.

Yes, you can submit multiple applications within the above focus areas and evaluation criteria as mentioned. Please note that each application is associated with one email address. Therefore, please use different email addresses if you are making more than one application.